Carbonic anhydrase inhibition with natural products: novel chemotypes and inhibition mechanisms.
Five genetically distinct classes of carbonic anhydrases (CAs, EC 4.2.1.1) are present in organisms all over the phylogenetic tree (α-, β-, γ-, δ-, and ζ-families). These metalloenzymes catalyze CO(2) hydration to bicarbonate and protons. Inhibition of α-CAs from vertebrates, including humans, with sulfonamides was exploited clinically for decades for various classes of diuretics and systemically acting antiglaucoma agents, whereas newer inhibitors are used as topically acting antiglaucoma drugs, anticonvulsants, antiobesity, antipain and antitumor agents/diagnostic tools. Recently, novel interesting chemotypes, in addition to the sulfonamide and sulfamate were discovered, many of which are based on natural products, such as phenols/polyphenols, phenolic acids, and coumarins. Their detailed mechanism of inhibition has been explained by means of kinetic and X-ray crystallographic studies, and can be used for the rational drug design of other agents. Possible applications for these new chemotypes in drug design of CA inhibitors are envisaged and discussed in detail in this review.
Supuran
Claudiu T
CT
Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Rm. 188, Via della Lastruccia 3, 50019, Sesto Fiorentino, Florence, Italy. claudiu.supuran@unifi.it
D000818:Animals; D001688:Biological Products / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*; D002257:Carbonic Anhydrase Inhibitors / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*; D002256:Carbonic Anhydrases / Q000737:chemistry / Q000378:metabolism*; D003198:Computer Simulation; D003374:Coumarins / Q000737:chemistry / Q000378:metabolism; D015195:Drug Design; D004789:Enzyme Activation / Q000187:drug effects*; D006801:Humans; D008958:Models, Molecular; D010636:Phenols / Q000737:chemistry / Q000378:metabolism; D011073:Polyamines / Q000737:chemistry / Q000378:metabolism
D001688:Biological Products; D002257:Carbonic Anhydrase Inhibitors; D003374:Coumarins; D010636:Phenols; D011073:Polyamines; D002256:Carbonic Anhydrases
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1583-7
18242985
Bioorg Med Chem. 2009 Apr 1;17(7):2654-7
19297172
Bioorg Med Chem. 2005 Jan 17;13(2):483-9
15598570
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4511-4
20580555
Biochim Biophys Acta. 2010 Feb;1804(2):362-73
19679201
Nature. 2008 Mar 6;452(7183):56-61
18322527
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16233-8
19805286
Bioorg Med Chem. 2008 Aug 1;16(15):7424-8
18579385
J Biol Chem. 2006 Feb 24;281(8):4993-9
16321983
Bioorg Med Chem. 2010 Apr 15;18(8):2822-8
20363143
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3467-74
20529676
Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3
20674354
Bioorg Med Chem. 2009 Jul 1;17(13):4503-9
19450983
Bioorg Med Chem. 2010 Jan 1;18(1):14-8
19962903
J Biomol Screen. 2008 Apr;13(4):265-75
18349420
Curr Pharm Des. 2008;14(7):622-30
18336307
Microbiology (Reading). 2010 Jan;156(Pt 1):23-29
19833770
J Enzyme Inhib Med Chem. 2009 Apr;24 Suppl 1:1-39
19330638
Bioorg Med Chem. 2007 Jul 1;15(13):4336-50
17475500
Bioorg Med Chem. 2008 Oct 15;16(20):9101-5
18819808
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
18167490
Curr Top Med Chem. 2007;7(9):901-8
17504135
FEBS Lett. 2004 Nov 19;577(3):439-45
15556624
J Med Chem. 2010 Mar 11;53(5):2277-85
20158185
Bioorg Med Chem. 2009 Apr 15;17(8):3207-11
19231207
J Med Chem. 2010 Jan 28;53(2):850-4
20028100
J Biol Chem. 2008 Sep 12;283(37):25475-25484
18617510
Curr Pharm Des. 2008;14(7):603-14
18336305
J Med Chem. 2010 Aug 12;53(15):5511-22
20590092
Phytochemistry. 2010 Apr;71(5-6):598-604
20137795
Med Res Rev. 2003 Mar;23(2):146-89
12500287
J Med Chem. 2010 Jan 14;53(1):335-44
19911821
Bioorg Med Chem Lett. 2008 Sep 15;18(18):5066-70
18723348
J Am Chem Soc. 2009 Mar 4;131(8):3057-62
19206230
Bioorg Med Chem. 2010 Mar 15;18(6):2159-2164
20185318